����Ӱҵ Director Statements

��Ӱҵ to Establish New Policies for Allowable Publication Costs

July 8, 2025 — At ��Ӱҵ, we have long upheld a strong commitment to open access.

Image of a lab tech testing a blood sample

FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries for genetic engineering

June 18, 2025 — Trials failed to inform participants about the international transfer.

��Ӱҵ to update policies and practices guiding subawards

May 1, 2025 — Announcing changes to ��Ӱҵ’s award structure that will enable ��Ӱҵ to maintain strong, productive, and secure foreign collaborations while better tracking how dollars are spent.

Accelerating Access to Research Results: New Implementation Date for the 2024 ��Ӱҵ Public Access Policy

April 30, 2025 — The 2024 Public Access Policy, originally slated to go into effect on December 31, 2025, will now be effective as of July 1, 2025.

��Ӱҵ Reviews Policies to Promote Academic Freedom

April 24, 2025 — ��Ӱҵ will prioritize academic freedom in pursuit of public trust.

����Ӱҵ

Breadcrumb